Duan C, Li Y, Yang W, Zhang C. Combination of 131 I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma. Biotechnology & Biotechnological Equipment 2018;32:974-81. [DOI: 10.1080/13102818.2018.1475254][Cited by in Crossref: 3][Article Influence: 0.8][Reference Citation Analysis]
Zhu ZX, Liao MH, Wang XX, Huang JW. Transcatheter Arterial Chemoembolization Plus 131I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Korean J Radiol 2016;17:882-92. [PMID: 27833404 DOI: 10.3348/kjr.2016.17.6.882][Cited by in Crossref: 3][Cited by in F6Publishing: 2][Article Influence: 0.5][Reference Citation Analysis]